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background: The nationwide acute safety outcomes and the role of catheter-directed thrombolysis (CDT) in treatment of caval deep vein 
thrombosis (DVT) are unknown.
methods: We used the Nationwide Inpatient Sample (NIS) database from 2005 to 2011 to identify all patients admitted with a principal discharge 
diagnosis of caval DVT (ICD-9-CM 453.2). Among a total of 2,674 patients admitted with caval DVT, 26.9% (718) underwent CDT. We evaluated the 
national trends in the utilization rates of CDT using unmatched patients. The comparative outcomes analysis was performed using propensity scores 
and Elixhauser comorbidity index to match the two treatment groups. After 1:1 matching we compared in-hospital outcomes between the patients 
treated with CDT plus anticoagulation (598 patients) versus anticoagulation alone (598 patients).
results: The national CDT utilization rates gradually increased from 16.0% in 2005 to 34.7% in 2011. The groups that were less likely to be treated 
with thrombolysis included females (22.4% versus 31.7%; p <0.001), and African Americans (21.2% versus 29.1%; p<0.001). The outcomes analysis 
of the matched groups showed that in-hospital mortality was not significantly different between the CDT group and the anticoagulation alone group 
(2.5% versus 1.2%; p= 0.132). The rates of blood transfusion, pulmonary embolism, intracranial bleeding, and acute renal failure were significantly 
higher in the CDT group, however the IVC filter placement rates were not significantly different between the two groups. The CDT group also had 
increased length of stay (8.4±6.6 versus 6.8±7.2 days; P < 0.001) and hospital charges ($109,436 ± 98,467 versus $51,626 ± 76,835; p<0.001) 
than the anticoagulation alone group.
conclusions: In this nationwide observational study, we found that in-hospital morbidity with catheter-directed thrombolysis remains higher 
than anticoagulation alone, however the in-hospital mortality was not significantly different between the two groups. We also found that CDT was 
associated with increased costs and healthcare resource utilization.
